. P.T.Akça G.,MSc. PT.Arın A.B.,MSc.PT.Demirören Ü.,MSc.PT.Tosun Ç.Ö., P.T.Özütemiz Ö.,PT. Maru N.,Akyol G.,PT. Yavuz H.

THE CORRELATION BETWEEN DISEASE DURATION AND SYMPTOMS, TRADITIONAL EVALUATION METHODS IN ANKYLOSING SPONDILITIS PATIENTS

AS Morning stiffness Chronic fatigue Sleep disturbance  ROM  Spinal  mobility  Back pain

To determine the relations between symptoms and traditional evaluation methods in ankylosing spondilitis (AS) patients who have disease duration less than ten years (group 1) and more than ten years (group 2). To determine the relations between symptoms and traditional evaluation methods in ankylosing spondilitis (AS) patients who have disease duration less than ten years (group 1) and more than ten years (group 2).

●254 AS patients in ●10 y  125 patients (Group 1) ●10 y  129 patients (Group 2) ●20 sessions ( 2 passive, 3 active ) ●254 AS patients in ●10 y  125 patients (Group 1) ●10 y  129 patients (Group 2) ●20 sessions ( 2 passive, 3 active )

●Spinal mobility evaluation  occiput-wall distance,schober test,cervical rotation,lumbar lateral flexion, intermalleolar distance and thorax expansion ●ROM evaluations  goniometric measurements ●The number of shortness in muscles,morning stiffness, sleep disturbance, chronic fatigue, muscle strength, walking distance ● VAS

-Seconder diseases (Neurological, cardiopulmonary or orthopaedical diseases e.g.) -Patients,who were unable to complete the therapy course. -Patients,taking additional therapy modalities to the conventional program(3 active,2 passive modalities) -Seconder diseases (Neurological, cardiopulmonary or orthopaedical diseases e.g.) -Patients,who were unable to complete the therapy course. -Patients,taking additional therapy modalities to the conventional program(3 active,2 passive modalities)

● Group 1 (69 male,56 female)  43.09±10.06 ● Group 2 (85 male,44 female)  58.33±17.26 ● Groups are compared (pre-treatment)  Group 1  trunk,upper and lower extremities’ muscles’ force  (p<0.05).  Group 2  morning stiffness,sleep disturbance,chronic fatigue and pain  (p<0.05)  Group 2  intermalleolar distance,schober,lumbar lateral flexion and thorax expansion  (p<0.05).

Parameters Group 1Group 2 p Trunk muscle force mean±S.D. 3.86± ± Upper limbs muscle force mean±S.D. 4.12± ± Lower limbs muscle force mean±S.D. 4.03± ± Table 1.The Comparison Measuruments Of Trunk,Upper And Lower Limbs Muscle Force In Two Groups (Pre-treatment)

Graphic 1.The Comparison Measuruments Of Intermalleolar Distance,Schober,Lumbar Lateral Flexion and Thorax Expansion In Two Groups (Pre-treatment)

Positive correlation (p<0.05) Intermalleolar distance (ID) Lumbar lateral flexion (LLF) Thorax expansion (TE) Pain (P) Morning stiffness (MS) Chronic Fatigue (CF) Group 1  (Pre and post treatment) treatment)

Middle level negative correlation (p<0.05) Lumbar flexion (LF) Pain (P) Morning stiffness (MS) Chronic fatigue (F) Group 1 (Pre and post treatment)

Table 2. The Correlation Between Lumbar Flexion Measurument And The Measuruments of Pain,Morning Stiffness And Chronic Fatigue In Group 1 (Pre And Post Treatment) Pearson Correlation PainMorning Stiffness Chronic Fatigue Lumbal flexion Pre treatment r: p:0.000 p: p:0.000 r: p:0.023 Lumbal flexion Post treatment r: p:0.000 r: p:0.000 r: P:0.000

Middle correlation (p<0.05) Shober test (ST) Finger to floor distance (FTFD) Lumbar side flexion (LSF) Intermalleolar distance (ID) Group 1 (Pre and post treatment)

Group 2  Disease related symptoms  (p<0.05) Group 2  Disease related symptoms  (p<0.05) Group 1  Spinal mobility  Group 1  Spinal mobility  Trunk,upper and lower Trunk,upper and lower extremities muscle force  (p<0.05) extremities muscle force  (p<0.05) Group 1  Spinal mobility  Group 1  Spinal mobility  Trunk,upper and lower Trunk,upper and lower extremities muscle force  (p<0.05) extremities muscle force  (p<0.05)

Middle level negative correlation (p<0.05) Lumbar flexion (LF) Pain (P) Morning stiffness (MF) Chronic fatigue (CF) Group 1-2 (Pre and post treatment)

●Disease related symptoms ● Spinal mobility ● Muscle force Negative effect

Kapidzik et al.(2002) claimed that disease duration has an influence on functional ability,pain,radiographic progression of disease and the reduction of range of motion in ankylosing spondyliytis patients. Kapidzik et al.(2002) claimed that disease duration has an influence on functional ability,pain,radiographic progression of disease and the reduction of range of motion in ankylosing spondyliytis patients. Altin et al. (2001) suggested that affecting patients’ daily life and pulmonary involvement are common in early AS compared to late AS. Altin et al. (2001) suggested that affecting patients’ daily life and pulmonary involvement are common in early AS compared to late AS. Our study is claimed that spinal mobility,muscle force and symptoms deteriorate with disease duration in AS patients. Our study is claimed that spinal mobility,muscle force and symptoms deteriorate with disease duration in AS patients.

Thank you…